LTR Pharma (ASX:LTP) partnered with pharmaceutical wholesaler Symbion to establish national distribution capabilities for Spontan, a nasal spray treatment for erectile dysfunction, according to a Wednesday filing with the Australian bourse.
Symbion will offer warehousing, inventory management, and nationwide distribution services for Spontan starting in March, the filing said.
The operational integration is scheduled for rollout in the second quarter, per the filing.
Shares were up 12% in midday trade Thursday.